Parenteral Antibiotic Therapy Duration in Young Infants With Bacteremic Urinary Tract Infections
- PMID: 31431480
- PMCID: PMC6855812
- DOI: 10.1542/peds.2018-3844
Parenteral Antibiotic Therapy Duration in Young Infants With Bacteremic Urinary Tract Infections
Abstract
Objectives: To determine the association between parenteral antibiotic duration and outcomes in infants ≤60 days old with bacteremic urinary tract infection (UTI).
Methods: This multicenter retrospective cohort study included infants ≤60 days old who had concomitant growth of a pathogen in blood and urine cultures at 11 children's hospitals between 2011 and 2016. Short-course parenteral antibiotic duration was defined as ≤7 days, and long-course parenteral antibiotic duration was defined as >7 days. Propensity scores, calculated using patient characteristics, were used to determine the likelihood of receiving long-course parenteral antibiotics. We conducted inverse probability weighting to achieve covariate balance and applied marginal structural models to the weighted population to examine the association between parenteral antibiotic duration and outcomes (30-day UTI recurrence, 30-day all-cause reutilization, and length of stay).
Results: Among 115 infants with bacteremic UTI, 58 (50%) infants received short-course parenteral antibiotics. Infants who received long-course parenteral antibiotics were more likely to be ill appearing and have growth of a non-Escherichia coli organism. There was no difference in adjusted 30-day UTI recurrence between the long- and short-course groups (adjusted risk difference: 3%; 95% confidence interval: -5.8 to 12.7) or 30-day all-cause reutilization (risk difference: 3%; 95% confidence interval: -14.5 to 20.6).
Conclusions: Young infants with bacteremic UTI who received ≤7 days of parenteral antibiotics did not have more frequent recurrent UTIs or hospital reutilization compared with infants who received long-course therapy. Short-course parenteral therapy with early conversion to oral antibiotics may be considered in this population.
Copyright © 2019 by the American Academy of Pediatrics.
Conflict of interest statement
POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.
Figures
Comment in
-
An End in Sight: Shorter Duration of Parenteral Antibiotics in Neonates.Pediatrics. 2019 Sep;144(3):e20191611. doi: 10.1542/peds.2019-1611. Epub 2019 Aug 20. Pediatrics. 2019. PMID: 31431481 No abstract available.
Similar articles
-
Bacteraemic urinary tract infection: management and outcomes in young infants.Arch Dis Child. 2016 Feb;101(2):125-30. doi: 10.1136/archdischild-2014-307997. Epub 2015 Jul 15. Arch Dis Child. 2016. PMID: 26177657
-
Trends in Intravenous Antibiotic Duration for Urinary Tract Infections in Young Infants.Pediatrics. 2017 Dec;140(6):e20171021. doi: 10.1542/peds.2017-1021. Epub 2017 Nov 2. Pediatrics. 2017. PMID: 29097611
-
Short duration of parenteral antibiotics in infants with urinary tract infections.Paediatr Child Health. 2023 Jun 13;28(7):411-416. doi: 10.1093/pch/pxad030. eCollection 2023 Nov. Paediatr Child Health. 2023. PMID: 37885598 Free PMC article.
-
Short versus standard duration oral antibiotic therapy for acute urinary tract infection in children.Cochrane Database Syst Rev. 2003;(1):CD003966. doi: 10.1002/14651858.CD003966. Cochrane Database Syst Rev. 2003. PMID: 12535494 Review.
-
Antibiotic prophylaxis for transrectal prostate biopsy.Cochrane Database Syst Rev. 2011 May 11;(5):CD006576. doi: 10.1002/14651858.CD006576.pub2. Cochrane Database Syst Rev. 2011. PMID: 21563156 Review.
Cited by
-
Association Between Antibiotic Duration and Recurrence of Urinary Tract Infection in the Neonatal Critical Care Unit.J Pediatr Pharmacol Ther. 2024 Jun;29(3):316-322. doi: 10.5863/1551-6776-29.3.316. Epub 2024 Jun 10. J Pediatr Pharmacol Ther. 2024. PMID: 38863857 Free PMC article.
-
Outcomes associated with initial narrow-spectrum versus broad-spectrum antibiotics in children hospitalized with urinary tract infections.J Hosp Med. 2024 Sep;19(9):777-786. doi: 10.1002/jhm.13390. Epub 2024 May 12. J Hosp Med. 2024. PMID: 38734985 Free PMC article.
-
Aligning Patient Safety and Stewardship: A Harm Reduction Strategy for Children.Curr Treat Options Pediatr. 2021;7(3):138-151. doi: 10.1007/s40746-021-00227-6. Epub 2021 Jul 12. Curr Treat Options Pediatr. 2021. PMID: 38624879 Free PMC article. Review.
-
Urinary Tract Infection in Children: A Narrative Review.Cureus. 2024 Jan 1;16(1):e51469. doi: 10.7759/cureus.51469. eCollection 2024 Jan. Cureus. 2024. PMID: 38298274 Free PMC article. Review.
-
Bacteremia and antimicrobial resistance pattern of uropathogens causing febrile urinary tract infection in a Pediatric University Hospital.Germs. 2023 Sep 30;13(3):210-220. doi: 10.18683/germs.2023.1387. eCollection 2023 Sep. Germs. 2023. PMID: 38146384 Free PMC article.
References
-
- Hoberman A, Chao HP, Keller DM, et al. . Prevalence of urinary tract infection in febrile infants. J Pediatr. 1993;123(1):17–23 - PubMed
-
- Greenhow TL, Hung YY, Herz AM, Losada E, Pantell RH. The changing epidemiology of serious bacterial infections in young infants. Pediatr Infect Dis J. 2014;33(6):595–599 - PubMed
-
- Thomson J, Cruz AT, Nigrovic LE, et al. ; Pediatric Emergency Medicine Collaborative Research Committee (PEM CRC) HSV Study Group . Concomitant bacterial meningitis in infants with urinary tract infection. Pediatr Infect Dis J. 2017;36(9):908–910 - PubMed
-
- Wallace SS, Brown DN, Cruz AT. Prevalence of concomitant acute bacterial meningitis in neonates with febrile urinary tract infection: a retrospective cross-sectional study. J Pediatr. 2017;184:199–203 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
